Avalon GloboCare Shares Rocket After Entry Into AMD AI Developer Program

2026-02-26 13:00:40 ET

Avalon GloboCare Corp. (NASDAQ: ALBT) surged sharply Thursday after the company announced it has been accepted into the Advanced Micro Devices (AMD) AI Developer Program, a move that investors interpreted as bolstering Avalon's AI development capabilities and future growth prospects. ( Investing.com )

Stock Soars on AI Development News

In pre-market trading Thursday, Avalon's stock climbed as much as over 130 % before paring some gains -- a dramatic move following the company's announcement that its AI-driven subsidiary, Avalon Quantum AI LLC (AQAI), has gained access to AMD's developer ecosystem.

The acceptance into the AMD AI Developer Program provides Avalon access to AMD Developer Cloud credits, advanced tools, training, and technical resources -- including high-performance computing platforms powered by AMD's Instinct accelerators and EPYC processors -- at no direct charge. These resources are designed to support and accelerate the development and optimization of AI applications.

Leveraging AMD's AI Ecosystem

Avalon said it plans to leverage AMD's tools to scale AQAI's automated commentary video generation systems, accelerate the development of enterprise documentation tools, and expand its AI-powered workflow automation platform. Company leadership framed the program entry as validation of its strategic pivot toward technology and AI-driven software platforms, positioning AQAI as a core growth driver for the company's future.

According to Interim CEO and COO Meng Li, participation in AMD's developer ecosystem reinforces Avalon's technical capabilities and provides access to a wider community of AI developers and support resources, helping the company pursue advanced AI workflows and scalable deployment.

Strategic Context and Growth Potential

The AMD Developer Program is a resource-rich environment for AI projects, giving participants access to compute resources, development tools, community forums, and training materials to help optimize and scale AI models and applications. For smaller or emerging AI developers like Avalon, this access can reduce barriers to entry in high-performance computing and model training cost structures.

Avalon's broader corporate strategy includes advancing its AI platforms alongside its diagnostic consumer products and generative AI initiatives -- including the FDA-registered KetoAir(TM) handheld breathalyzer and associated SaaS video platforms.

The post Avalon GloboCare Shares Rocket After Entry Into AMD AI Developer Program appeared first on PRISM MarketView .

COMTEX_474281049/2927/2026-02-26T13:00:40